01 2M/s Cipla Limited
02 1M/s. Apitoria Pharma Private Limited
03 1M/sHetero LabsLimited
01 1Anhydrous Nevirapine BP/USP/PH. Eur
02 1Nevirapine Ph.Eur
03 1Nevirapine USP
04 1Nevirapine USP/Ph. Eur
01 1WC-0023
02 1WC-0065
03 2WC-0140
01 4India
Date of Issue : 2025-07-11
Valid Till : 2028-06-25
Written Confirmation Number : WC-0023
Address of the Firm : Sy. No\'s. 52,53,58,59,61 to 78, 127 & 128, Pydibhimavaram Village & Sy. No\'s. ...
Anhydrous Nevirapine BP/USP/PH. Eur
Date of Issue : 2025-06-20
Valid Till : 2028-07-02
Written Confirmation Number : WC-0140
Address of the Firm : D-22, M.I.D.C, Industrial Area,Kurkumbh, Taluka
Date of Issue : 2025-06-20
Valid Till : 2028-07-02
Written Confirmation Number : WC-0140
Address of the Firm : D-22, M.I.D.C, Industrial Area,Kurkumbh, Taluka
Date of Issue : 2022-09-30
Valid Till : 2025-08-15
Written Confirmation Number : WC-0065
Address of the Firm : Unit-IX, Plot No. 2, Hetero Infrastructure- SEZ Ltd., N. Narasapuram (Village), ...
66
PharmaCompass offers a list of Nevirapine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nevirapine manufacturer or Nevirapine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nevirapine manufacturer or Nevirapine supplier.
PharmaCompass also assists you with knowing the Nevirapine API Price utilized in the formulation of products. Nevirapine API Price is not always fixed or binding as the Nevirapine Price is obtained through a variety of data sources. The Nevirapine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A BI-RG-587 & CD4-IgG manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of BI-RG-587 & CD4-IgG, including repackagers and relabelers. The FDA regulates BI-RG-587 & CD4-IgG manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. BI-RG-587 & CD4-IgG API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of BI-RG-587 & CD4-IgG manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A BI-RG-587 & CD4-IgG supplier is an individual or a company that provides BI-RG-587 & CD4-IgG active pharmaceutical ingredient (API) or BI-RG-587 & CD4-IgG finished formulations upon request. The BI-RG-587 & CD4-IgG suppliers may include BI-RG-587 & CD4-IgG API manufacturers, exporters, distributors and traders.
click here to find a list of BI-RG-587 & CD4-IgG suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A BI-RG-587 & CD4-IgG written confirmation (BI-RG-587 & CD4-IgG WC) is an official document issued by a regulatory agency to a BI-RG-587 & CD4-IgG manufacturer, verifying that the manufacturing facility of a BI-RG-587 & CD4-IgG active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting BI-RG-587 & CD4-IgG APIs or BI-RG-587 & CD4-IgG finished pharmaceutical products to another nation, regulatory agencies frequently require a BI-RG-587 & CD4-IgG WC (written confirmation) as part of the regulatory process.
click here to find a list of BI-RG-587 & CD4-IgG suppliers with Written Confirmation (WC) on PharmaCompass.
We have 3 companies offering BI-RG-587 & CD4-IgG
Get in contact with the supplier of your choice:
